Molecular Genetics of 21-Hydroxylase Deficiency

被引:0
|
作者
Wedell, Anna [1 ]
机构
[1] Karolinska Inst, Dept Mol Med & Surg, Karolinska Univ Hosp, Ctr Inherited Metab Dis, SE-17176 Stockholm, Sweden
来源
PEDIATRIC ADRENAL DISEASES | 2011年 / 20卷
关键词
CONGENITAL ADRENAL-HYPERPLASIA; MAJOR HISTOCOMPATIBILITY COMPLEX; STEROID; 21-HYDROXYLASE; DISEASE MANIFESTATION; TENASCIN-X; GENES; MUTATIONS; COMPONENT; GENOTYPE; HLA;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
More than 95% of all cases of congenital adrenal hyperplasia are caused by deficiency of steroid 21-hydroxylase, an enzyme encoded by the CYP21A2 gene. The severity of the clinical symptoms varies according to the level of residual 21-hydroxylase activity. The CYP21A2 gene is located in the HLA class Ill region, as a component of so called RCCX modules containing homologous genes repeated in tandem. Misalignment followed by unequal crossing over as well as gene conversion events result in a high degree of variation in gene copy number as well as gene sequence in this genomic region. The presence of a highly homologous pseudogene, CYP21A1P, forms the basis for the relatively high incidence of 21-hydroxylase deficiency as deleterious sequences can be transferred from CYP21A1P to CYP21A2. Despite the complexity of the locus, safe approaches for genotyping are established, and genotype phenotype relationships have been documented making genotyping a valuable complement to biochemical investigations in the diagnostics of 21-hydroxylase deficiency. This is of particular importance in relation to family investigations and neonatal screening. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:80 / 87
页数:8
相关论文
共 50 条